Usually not much is accomplished during a lame-duck session of Congress, but a major piece of health care legislation is on deck this week.
The 21st Century Cures Act is a sweeping bill that would boost National Institutes of Health funding for translational research, and speed up the Food and Drug Administration's ability to approve life-saving drugs and medical devices, among many other things.
You can read all 1,000 pages of this bill here – including the medical device provisions aimed at accelerating approval, under the guise of innovation and efficient marketing of life-saving devices, starting on page 233. This bill is sausage laced with poison.
Among the voices sounding an alarm on this safety deficit is U.S. Rep. Mike Fitzpatrick (R-PA), who has worked closely with us and other advocates on this problem.
Still, Fitzpatrick voted "Nay" on the Cures Act in 2015, and then gathered a bipartisan coalition to attack the problem.
Second, Fitzpatrick rallied the support of a colleague from across the aisle to propose the Medical Device Guardians Act (H.R. 5404), which requires "self-reporting" of design flaws and complications associated with their use. Though this is a mandate of the American Medical Association's Code of Medical Ethics, it is not required by law. The legislation has been collecting dust on the House docket since last June.
Likely this week, the 21st Century Cures Act is poised to go back through the House of Representatives on its way to the Senate. The House is likely to invoke a "suspension of the rules" a maneuver that's supposed to be for noncontroversial bills. If so, and if no one objects, it will go directly to the Senate for passage.
As advocates for patient safety, we call on Fitzpatrick and his colleagues who grasp the danger of the Act's medical device provisions to raise those objections.
Securing the medical device regulatory space efficiently may be a tall order for a Congress in gridlock. But passage of the Medical Device Guardians Act, which enjoys the support of harmed patients and their advocates, not big money interests, will be an even taller one.
Still, our best hope lies with Fitzpatrick, who soon will be leaving Congress. He has clarity enough on this problem to rise once again and object to leaving unsuspecting Americans in harm's way. Fitzpatrick knows that Congress can add the provisions of H.R. 5404 into the 21st Century Cures Act –to provide FDA with the real-time public health data it needs to defend patients from unsafe medical devices.